Haemonetics shares jump on expanded plasma device rollout
Haemonetics said it is expanding the rollout of plasma collection devices, with its stock up 17% to $119.56, on pace for its highest close since $116.97.
Haemonetics stock surged Thursday after the medical-device maker disclosed an expanded rollout of its plasma collection devices, a move that could open the door to significant recurring revenue. 97.